Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Your healthcare provider may recommend using the same medications used to treat stage 1 multiple myeloma for up to one year. A stem cell transplant, also known as a bone marrow transplant ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

The mother of a seven-year-old with a life-threatening blood disorder says despite treatments being the same as cancer, they do not receive the same charity support.

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

Bone marrow transplant is associated with accelerated brain aging and worse neurocognitive functioning, data suggest.

The facility of bone marrow transplant is not available for ... chronic lymphoid leukaemia, multiple myeloma, diffuse large B-cell lymphoma, Hodgkin's lymphoma, myelodysplastic syndrome ...

Ciltacabtagene autoleucel improved minimal residual disease negativity and sustained responses vs standard care in ...

Multiple myeloma is a cancer involving plasma cells ... is in remission after six months of chemotherapy and a bone marrow transplant. He manages the disease by taking a daily chemotherapy pill.

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...